This protocol aims to provide detailed experimental steps of a cold atmospheric plasma treatment on neural stem cells and immunofluorescence detection for differentiation enhancement.
As the development of physical plasma technology, cold atmospheric plasmas (CAPs) have been widely investigated in decontamination, cancer treatment, wound healing, root canal treatment, etc., forming a new research field named plasma medicine. Being a mixture of electrical, chemical, and biological reactive species, CAPs have shown their abilities to enhance nerve stem cells differentiation both in vitro and in vivo and are becoming a promising way for neurological disease treatment in the future. The much more exciting news is that using CAPs may realize one-step, and safely directed, differentiation of neural stem cells (NSCs) for tissue transportation. We demonstrate here the detailed experimental protocol of using a self-made CAP jet device to enhance NSC differentiation in C17.2-NSCs and primary rat neural stem cells, as well as observing the cell fate by inverted and fluorescence microscopy. With the help of immunofluorescence staining technology, we found both the NSCs showed an accelerated differential rate than the untreated group, and ~75% of the NSCs selectively differentiated into neurons, which are mainly mature, cholinergic, and motor neurons.
The directed differentiation of NSCs into a certain lineage for tissue transportation is considered one of the most promising therapies for neurodegenerative and neurotraumatic diseases1. For example, catecholaminergic dopaminergic neurons are especially desired in Parkinson's disease (PD) treatment. However, traditional methods to prepare the desired cells for transportation have many drawbacks, such as chemical toxicity, scar formation, or others, which largely hampers the applications of NSCs in regenerative medicine2. Therefore, it is very necessary to find a novel and safe way for NSC differentiation.
Plasma is the fourth state of matters, following solid, liquid, and gas, and it constitutes more than 95% of matters in the whole universe. Plasma is electrically neutral with unbound positive/negative and neutral particles and is usually generated by a high-voltage discharge in the lab. In the last two decades, the application of plasma in biomedicine has attracted huge attention worldwide as the development of cold atmospheric pressure plasma technology. Thanks to this technic, stable low-temperature plasma can be generated in the surrounding air at atmosphere without arc formation and consists of various reactive species, such as reactive nitrogen species (RNS), reactive oxygen species (ROS), ultraviolet (UV) radiation, electrons, ions, and electrical field3. CAPs have unique advantages for micro-organism inactivation, cancer therapy, wound healing, treatment of skin diseases, cell proliferation, and cell differentiation4,5,6,7. In previous work, we demonstrated that cold atmospheric plasma jet can enhance the differentiation of NSCs in both murine neural stem cell C17.2 (C17.2-NSCs) and primary rat neural stem cells, exhibiting a great potential to become a powerful tool for the directed differentiation of NSCs8. Although the mechanism of CAP enhancement of NSC differentiation is not fully understood yet, NO generated by CAPs has been proved to be a key factor in the process. In this work, we aim to provide a detailed experimental protocol of using an atmospheric pressure helium/oxygen plasma jet for the treatment of NSCs in vitro, cell preparation and pretreatment, morphology observation by inverted microscope, and fluorescence microscopy observation of immunofluorescence staining.
1. Cell Cultures and Predifferentiation
2. Preparation of the Plasma Jets
3. Acquisition of the Jets
4. Plasma Treatment of Neural Stem Cell
5. Neural Stem Cell Differentiation
6. Immunofluorescence Staining
Cell morphology was observed under the inverted microscope every day after the CAP treatment. Figure 2 shows the ordinary inverted phase-contrast light microscope images of the cell differentiation in both cell lines. The plasma-treated group exhibits an accelerated differentiation rate and a high differentiation ratio compared to the control and gas flow group.
The immunofluorescent results of C17.2-NSCs and primary rat NSCs cultured for 6 d after the treatment are shown in Figure 3 and Figure 4, respectively. Nestin (+, green) decreased, β-Tubulin III (+, red) significantly increased, and O4 (+, green) slightly increased in both cell lines compared to the control group. CAP treatments of 60 s effectively enhanced the C17.2-NSCs into neuronal lineage compared to the control group and the gas flow treatment group. Pure gas flow had no visible effect on the NSC differentiation.
Figure 5 shows the neuronal fate specification in the 60 s plasma treatment group. Strong expressions of NF200 (for mature neuron), ChAT (for cholinergic neuron), and LHX3 (for motor neuron) were observed. GABAergic and serotonergic neurons were rarely seen, while no dopaminergic neurons were detected.
Figure 1: Schematic of the experimental set-up. The plasma jet device is connected to the output wire of the high-voltage power supply. The high-voltage probe with oscilloscope is used to detect the output voltage. When the working gases are flowing through the syringe and the high voltage is on, the plasma jet will be generated and propagate into the open air. Please click here to view a larger version of this figure.
Figure 2: Ordinary inverted phase-contrast light microscope images for C17.2-NSCs and primary rat NSCs. This figure is adapted from Xiong et al.8 with permission. Please click here to view a larger version of this figure.
Figure 3: Immunofluorescence detection of untreated C17.2-NSCs (left), 60 s gas flow-treated C17.2-NSCs (middle), and 60 s plasma-treated C17.2-NCSs (right) for 6 d of culture. Nestin (+, green)/Hoechst; β-Tubulin III (+, red)/Hoechst; O4 (+, green)/Hoechst. The nuclear is stained with Hoechst 33258. This figure is adapted from Xiong et al.8 with permission. Please click here to view a larger version of this figure.
Figure 4: Immunofluorescence detection of untreated primary rat NSCs (left), 60 s gas flow-treated primary rat NSCs (middle), and 60 s plasma-treated primary rat NSCs (right) for 6 d of culture. Nestin (+, green)/Hoechst; β-Tubulin III (+, red)/Hoechst; O4 (+, green)/Hoechst. The nuclear is stained with Hoechst 33258. This figure is adapted from Xiong et al.8 with permission. Please click here to view a larger version of this figure.
Figure 5: Neuronal fate specification studied by immunofluorescence in the 60 s plasma treatment group. NF200 (+, red)/Hoechst; ChAT (+, red)/Hoechst; LHX3 (+, red)/Hoechst; GABA (+, red)/Hoechst; Serotonin (+, red)/Hoechst; TH (+, red)/Hoechst. The nuclear is stained with Hoechst 33258. This figure is adapted from Xiong et al.8 with permission. Please click here to view a larger version of this figure.
C17.2-NSCs is a kind of immortalized neural stem cell line from neonatal mouse cerebellar granular layer cells, developed by Snyder and others10,11. C17.2-NSCs can differentiate into neurons, astrocytes, and oligodendrocytes and are widely used in neuroscience12. In our previous study, CAPs could enhance the differentiation of C17.2-NSCs into neurons. A proof-of-principle study was also carried out using primary rat NSCs, and the effect of the plasma exposure on the primary rat NSCs was qualitatively similar to that of the C17.2-NSCs, with a stronger differentiation of neurons. CAPs, a novel physicochemical technology, may represent a promising tool for neurological disease therapy, such as Alzheimer’s disease, PD, spinal cord injury, and others.
CAP treatment offers a one-step way to enhance both C17.2 NSC and primary rat NSC differentiation in vitro with a short treatment time and little cell damage. Moreover, the results showed a ~75% directed differentiation into neurons, which made plasma treatment a promising method for future tissue transplantations in the clinic. However, the current protocol only recruited one type of CAP devices for NSC differentiation. The limitation of using this microplasma is the nonuniformity when the plasma plume treats the 12-well plate. Future work will consider using a large-volume plasma device or plasma-activated medium for uniform treatment.
There are several critical steps within the protocol. First, each washing step must be carefully performed, for the cells are easily detached after the differentiation. The procedures of fixation and permeabilization are other critical steps in immunostaining. The fixation is necessary to preserve the morphology and antigenicity of the cells13. Permeabilization allows antibodies to bind to the intracellular and nuclear antigens14. The optimal time point for fixation and permeabilization must be determined through pretest. Immunofluorescence blocking and antibody incubation are as important as gentle washing steps. It is recommended to use animal serum from the same source as the secondary antibody to cover the endogenous nonspecific binding proteins. For optimal results, the final dilution ratio of the antibody must be determined by pretest. As for the plasma treatment, the plasma dosage must be applied very carefully; long-time and intense plasma treatment will induce cell apoptosis or necrosis. Therefore, the treatment time and distance must be pretested.
In summary, this manuscript provides a step-by-step protocol for inducing NSC differentiation by using an atmospheric plasma jet and highlights critical issues during the whole process. CAPs can enhance the differentiation of NSCs into neurons and will clearly be beneficial for the treatment of neurological diseases. It is also worthwhile to note that the current protocol only focuses on the in vitro effect of CAPs on NSCs. It is necessary for future studies to evaluate the effect of plasma in vivo using mouse models of nerve injury.
The authors have nothing to disclose.
This work was supported by the Huazhong Scholar Program, the Independent Innovation Fund of the Huazhong University of Science and Technology (No. 2018KFYYXJJ071), and the National Natural Science Foundation of China (Nos. 31501099 and 51707012).
Coverslip | NEST | 801008 | |
Poly-D-lysine | Beyotime | P0128 | |
DMEM medium | HyClone | SH30022.01B | stored at 4 °C |
DMEM/F12 medium | HyClone | SH30023.01B | stored at 4 °C |
N2 supplement | Gibco | 17502048 | stored at -20 °C and protect from light |
B27 supplement | Gibco | 17504044 | stored at -20 °C and protect from light |
Fetal bovine serum | HyClone | SH30084.03 | stored at -20 °C, avoid repeated freezing and thawing |
Donor Horse serum | HyClone | SH30074.03 | tored at -20 °C, avoid repeated freezing and thawing |
Penicillin/Streptomycin | HyClone | SV30010 | stored at 4 °C |
Trypsin | HyClone | 25300054 | stored at 4 °C |
PBS solution | HyClone | SH30256.01B | stored at 4 °C |
4% paraformaldehyde | Beyotime | P0098 | stored at -20 °C |
TritonX-100 | Sigma | T8787 | |
Normal Goat Serum Blocking Solution | Vector Laboratories | S-1000-20 | stored at 4 °C |
anti-Nestin | Beyotime | AF2215 | stored at -20 °C, avoid repeated freezing and thawing |
anti-β-Tubulin III | Sigma Aldrich | T2200 | stored at -20 °C, avoid repeated freezing and thawing |
anti-O4 | R&D Systems | MAB1326 | stored at -20 °C, avoid repeated freezing and thawing |
anti-NF200 | Sigma | stored at -20 °C, avoid repeated freezing and thawing | |
anti-ChAT | Sigma | stored at -20 °C, avoid repeated freezing and thawing | |
anti- LHX3 | Sigma | stored at -20 °C, avoid repeated freezing and thawing | |
anti-GABA | Sigma | stored at -20 °C, avoid repeated freezing and thawing | |
anti-Serotonin | Abcam, Cambridge, MA | stored at -20 °C, avoid repeated freezing and thawing | |
anti-TH | Abcam, Cambridge, MA | stored at -20 °C, avoid repeated freezing and thawing | |
Immunol Staining Primary Antibody Dilution Buffer | Beyotime | P0103 | stored at 4 °C |
Cy3 Labeled Goat Anti-Rabbit IgG | Beyotime | A0516 | stored at -20 °C and protect from light |
Alexa Fluor 488- Labeled Goat | Beyotime | A0428 | stored at -20 °C and protect from light |
Anti-Mouse IgG | |||
12-well plate | corning | 3512 | |
25 cm2 flask | corning | 430639 | |
Hoechst 33258 | Beyotime | C1018 | stored at -20 °C and protect from light |
Mounting medium | Beyotime | P0128 | stored at -20 °C and protect from light |
Light microscope | Nanjing Jiangnan Novel Optics Company | XD-202 | |
Fluorescence microscopy | Nikon | 80i | |
High – voltage Power Amplifier | Directed Energy | PVX-4110 | |
DC power supply | Spellman | SL1200 | |
Function Generator | Aligent | 33521A | |
Oscilloscope | Tektronix | DPO3034 | |
High voltage probe | Tektronix | P6015A |